Kulkarni K - Search Results

1

Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer.

Wu D, Plyku D, Kulkarni K, Garcia C, Atkins F, Tefera E, Burman KD, Wartofsky L, Van Nostrand D. Wu D, et al. Among authors: kulkarni k. Clin Nucl Med. 2021 Apr 1;46(4):283-288. doi: 10.1097/RLU.0000000000003505. Clin Nucl Med. 2021. PMID: 33492859

2

Positron emission tomography in Dyke-Davidoff-Masson syndrome.

Kulkarni K, Sperling MR, Intenzo C. Kulkarni K, et al. Clin Nucl Med. 2005 Sep;30(9):625-7. doi: 10.1097/01.rlu.0000174238.50096.26. Clin Nucl Med. 2005. PMID: 16100487

3

Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan.

Garcia CA, Van Nostrand D, Atkins F, Acio E, Butler C, Esposito G, Kulkarni K, Majd M. Garcia CA, et al. Among authors: kulkarni k. Mol Imaging Biol. 2006 Jan-Feb;8(1):24-9. doi: 10.1007/s11307-005-0030-3. Mol Imaging Biol. 2006. PMID: 16333529

4

The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer.

Kulkarni K, Van Nostrand D, Atkins F, Aiken M, Burman K, Wartofsky L. Kulkarni K, et al. Thyroid. 2006 Oct;16(10):1019-23. doi: 10.1089/thy.2006.16.1019. Thyroid. 2006. PMID: 17042688

5

Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma.

Van Nostrand D, Atkins F, Moreau S, Aiken M, Kulkarni K, Wu JS, Burman KD, Wartofsky L. Van Nostrand D, et al. Among authors: kulkarni k. Thyroid. 2009 Oct;19(10):1093-8. doi: 10.1089/thy.2008.0339. Thyroid. 2009. PMID: 19732012

6

Effective reduction of brown fat FDG uptake by controlling environmental temperature prior to PET scan: an expanded case series.

Garcia C, Bandaru V, Van Nostrand D, Chennupati S, Atkins F, Acio E, Kulkarni K, Majd M. Garcia C, et al. Among authors: kulkarni k. Mol Imaging Biol. 2010 Dec;12(6):652-6. doi: 10.1007/s11307-010-0298-9. Mol Imaging Biol. 2010. PMID: 20237858

7

Salivary gland malignancy and radioiodine therapy for thyroid cancer.

Klubo-Gwiezdzinska J, Van Nostrand D, Burman KD, Vasko V, Chia S, Deng T, Kulkarni K, Wartofsky L. Klubo-Gwiezdzinska J, et al. Among authors: kulkarni k. Thyroid. 2010 Jun;20(6):647-51. doi: 10.1089/thy.2009.0466. Thyroid. 2010. PMID: 20470209

8

Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice.

Van Nostrand D, Bandaru V, Chennupati S, Wexler J, Kulkarni K, Atkins F, Mete M, Gadwale G. Van Nostrand D, et al. Among authors: kulkarni k. Thyroid. 2010 Oct;20(10):1113-9. doi: 10.1089/thy.2009.0429. Thyroid. 2010. PMID: 20883172

9

Detectability of foci of radioiodine uptake in the thyroid bed and neck comparing pinhole with parallel-hole collimators.

Kulkarni K, Van Nostrand D, Mete M, Burman K, Wartofsky L. Kulkarni K, et al. Nucl Med Commun. 2011 May;32(5):369-74. doi: 10.1097/MNM.0b013e3283428d62. Nucl Med Commun. 2011. PMID: 21394048

10

Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?

Kulkarni K, Van Nostrand D, Atkins F, Mete M, Wexler J, Wartofsky L. Kulkarni K, et al. Nucl Med Commun. 2014 Feb;35(2):210-6. doi: 10.1097/MNM.0000000000000034. Nucl Med Commun. 2014. PMID: 24177041 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

707 results

Search Page

Filters